P

Polaris Founders Capital

2 employees

Polaris Founders Capital makes substantial investments in fast-growing companies.

Investor insights

Sectors invested in

Biotechnology3
Pharmaceutical2
Medical2
Health Care2
Genetics1
gene therapy1
Health Diagnostics1
Neuroscience1
Electronic Health Record (EHR)1
Health Insurance1
mHealth1
Neurodegenerative Diseases1
Alzheimer's1
Alzheimer's Disease1
ALS1
Amyotrophic Lateral Sclerosis1

Funding rounds participated in

$105M sweet spot round size

Most of their 4 investments are in rounds between $24M and $105M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Date founded

1997

Investments made

A

Amylyx Pharmaceuticals raised $135M on July 20, 2021

Investors: Woodline Partners LP, Marshall Wace, Morningside Venture Capital 晨兴资本, Viking Global Investors, Perceptive Advisors and Polaris Founders Capital

S

Sesame raised $24M on April 27, 2021

Investors: Coefficient Capital, Entrée Capital, Atreides Management, LP, Industry Ventures, Giant Ventures, General Catalyst and Polaris Founders Capital

A

Akouos raised $105M on March 3, 2020

Investors: Sofinnova Ventures, Russia technology fund, Wu Capital （双湖资本）, Surveyor Capital, RA Capital Management, L.P., PAG, Partners HealthCare and Polaris Founders Capital

F

Frequency Therapeutics raised undisclosed on July 23, 2019

Investors: RTW Investments, LP, Perceptive Advisors, COBRO VENTURES, INC, みずほ証券プリンシパルインベストメント（株）, Axil Capital Partners, Axil Capital Advisors K.K., Taiwania Capital and Polaris Founders Capital

FAQ